Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections

Journal of Chemotherapy

Volumn 9, Issue 3, 1997, Pages 203-207

  Mavromanolakis, E ^a   Maraki, S ^a   Samonis, G ^b   Tselentis, Y ^a   Cranidis, A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Fecal flora; Nitrofurantoin; Norfloxacin; Trimethoprim sulfamethoxazole; Urinary tract infections

Indexed keywords

COTRIMOXAZOLE; NITROFURANTOIN; NORFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS; ESCHERICHIA COLI; FECES CULTURE; FECES MICROFLORA; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INTESTINE FLORA; URINARY TRACT INFECTION;

EID: 0030809280     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.3.203     Document Type: Article

References (14)

1. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993; 329: 1328-34.
2. Brumfitt W, Hamilton-Miller JMT. Therapeutic update: Prophylactic antibiotics for recurrent urinary tract infections. J Antimicrob Chemother 1990; 25: 505-12.
3. Finegold SM. Interaction of antimicrobial therapy and intestinal flora. Am J Clin Nutr 1970; 23:1466-71.
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved Standard M2-A4. 1990. National Committee for Clinical Laboratory Standards, Villanova, Pa.
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A2. 1990. National Committee for Clinical Laboratory Standards, Villanova, Pa.
6. Turck M, Ronald AR, Petersdorf RG. Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of resistance in chronic bacteriuria. N Engl J Med 1968; 278: 422-7.
7. Edlund C, Nord CE. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora. Infection 1988; 16: 8-12.
8. Stamm WE, Counts GW, Wagner KF, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med 1980; 92: 770-5.
9. Stamey TA, Condy M, Mihara G. Prophylactic efficacy of nitrofuran-toin macrocrystals and trimethoprim-sulfamethoxazole in urinary tract infections: biologic effects on the vaginal and rectal flora. N Engl J Med 1977; 296: 780-3.
10. Toivanen A, Kasanen A, Sundquist H, et al. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy 1976; 22: 97-103.
11. Lincoln K, Lidiy-Janson G, Winberg J. Resistant urinary infections resulting from changes in resistance pattern of fecal flora induced by sulfonamide and hospital environment. Br Med J 1970; 3: 305-9.
12. Schaeffer AJ, Sisney GA. Efficacy of norfloxacin in urinary tract infections: biological effects on vaginal and fecal flora. J Urol 1985; 133: 628-30.
13. Gruneberg RN, Smellie JM, Leakey A, et al. Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects. Br Med J 1976; 2: 206-8.
14. Nord CE. Effect of new quinolones on the human gastrointestinal microflora. Rev Infect Dis 1989; 11(suppl 1): 193-6.